Compare PROF & FC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PROF | FC |
|---|---|---|
| Founded | N/A | 1983 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Other Consumer Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.8M | 202.8M |
| IPO Year | 2017 | 1994 |
| Metric | PROF | FC |
|---|---|---|
| Price | $5.68 | $18.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $12.00 | ★ $26.00 |
| AVG Volume (30 Days) | ★ 120.7K | 55.0K |
| Earning Date | 05-07-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $16,098,000.00 | ★ $267,067,000.00 |
| Revenue This Year | $92.40 | $3.15 |
| Revenue Next Year | $64.10 | $4.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 50.73 | N/A |
| 52 Week Low | $3.92 | $11.16 |
| 52 Week High | $8.95 | $26.81 |
| Indicator | PROF | FC |
|---|---|---|
| Relative Strength Index (RSI) | 27.52 | 35.47 |
| Support Level | $4.97 | $15.87 |
| Resistance Level | $6.06 | $21.15 |
| Average True Range (ATR) | 0.35 | 0.76 |
| MACD | -0.10 | -0.13 |
| Stochastic Oscillator | 16.23 | 17.20 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.